You are here

24-06-2019 | © istockphotos.com 2 mins read

Microbiota: a cure for obesity?

Effective treatment for obesity remains a challenge and the only intervention proven to maintain weight loss is bariatric surgery. Intrigued by the beneficial effect that this procedure has on the composition of gut microbiota, Dr Fredrik Bäckhed explores the possibility of mimicking these changes to develop a treatment for obesity that won’t require going under the knife.

08-05-2019 | © picture 3 mins read

Is political participation contagious?

ELECTION SERIES #7

Why are some people more likely to vote or stand for election than others? Researchers based in Sweden are doing some deep data diving to find out how our social surroundings and our genes influence political participation.

22-05-2018 | © picture 6 mins read

Sailing the mysteries of old maps

Dr Joaquim Alves Gaspar is a man of the sea. After many years in the Portuguese Navy, he gave up plans to become an admiral in favour of pursuing a PhD in the History of Cartography. This second career led him to receive an ERC Starting Grant, the first awarded in this budding discipline. With his highly multidisciplinary team (he likes to say that, to work with him, one must be a mathematician fluent in Latin), and the experience obtained as a navigator and navigational instructor, Dr Gaspar hopes to understand how and when the first nautical charts were created. The MEDEA-CHART team is the best place in Portugal, and probably in the world, to study the history of nautical cartography, hoping that this work will provide the domain with its rightful recognition within world history.

05-03-2018 | © Stockholm Resilience Centre, S-E. Arndt/Azote 6 mins read

Climate change: How on Earth to draw the boundary lines?

11-05-2017 | Portrait and illustration: Photo Evolutionary Biology group (Isabel Gordo) | llustration: Macrophages with Escherichia coli 3 mins read

New knowledge to fight back against antibiotic resistance

The use and misuse of antibiotics has accelerated the emergence of drug-resistant bacterial strains, threatening our ability to treat common diseases. EU-funded research has shed new light on the mechanisms behind these microbial mutations, with implications for our understanding of diseases and resistance to treatment.

01-04-2017 | © picture

Frontier science and business that makes a difference

Maria Brandão de Vasconcelos, together with her colleague Filipa Matos Baptista, Henrique Veiga-Fernandes (ERC grantee), Diogo Fonseca Pereira and Sílvia Arroz Madeira, founded StemCell2MAX in 2015. The company is a biotechnology start-up, specialised in cell based therapies, including novel solutions to multiply the scarcely available blood stem cells, addressing an enormous demand for research and cancer treatment. StemCell2MAX technology is based on Prof. Veiga-Fernandes's ground-breaking discoveries in hematopoietic stem cell biology.

Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."

30-03-2017 | © picture 2 mins read

Together, we can achieve a lot

Ole Kamstrup, MD., MSc., is a pensioner and lives north of Copenhagen in Denmark. He has been diagnosed with Parkinson's disease ten years ago. Since 2013, Mr Kamstrup has been in contact with Professor Deniz Kirik, a neuroscientist at Lund University in Sweden. Professor Kirik, who was awarded an ERC Starting Grant in 2009, develops new therapies for Parkinson’s disease, using viral vectors to deliver therapeutic genes to the brain. An ERC Proof of Concept grant enabled him to start carrying out a market evaluation and writing a business plan for the promising therapy.

Originally published in March 2017 as part of the multimedia campaign "ERC - 10 years – 10 portraits."

20-07-2016 | © picture 2 mins read

Can we prevent cardiovascular diseases in healthy individuals?

Cardiovascular diseases (CVD) are a major cause of morbidity and mortality in Europe. Prevention relies on measuring traditional risk factors such as age, gender, hypertension, diabetes, hypercholesterolemia and smoking. However, many individuals, apparently at low-risk, still develop CVD. Improving predictions beyond the traditional risk factors is the challenge undertaken by Prof. Olle Melander.

29-06-2016 | © picture 2 mins read

Stem cells: from frontier research project to promising spin-off company

Haematopoietic Stem Cells (HSCs) are blood cells located in the bone marrow. These cells are extensively used in research to develop treatments for many severe diseases, including HIV and multiple sclerosis, and their transplant is a key therapy for certain types of cancer like leukemia and multiple myeloma. However, the use of HSCs is seriously constrained by their limited availability since growing them in the lab does not produce very large quantities. There is therefore an urgent need for methods allowing scientists to multiply HSCs, without losing any of their properties.

21-03-2016 | Image: © National Museum of Denmark 2 mins read

International recognition for ERC-funded research in archaeology

During the 3rd and 2nd millennium BC, the European continent experienced important social and cultural transformations, with the introduction of metal and the emergence of new languages and identities. Recent theories suggest that these major changes were triggered by people’s migrations and cultural transmissions, challenging the perception of European prehistory as a series of unrelated local developments.